Hemostatic drug therapies for acute, nontraumatic intracerebral hemorrhage

Stroke

Volumn 38, Issue 1, 2007, Pages 204-205

  Al Shahi, Rustam ^a,b   You, Hong ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Acute cerebral hemorrhage; Emergency treatment of stroke; Intracerebral hemorrhage; Other stroke treatment, medical

Indexed keywords

AMINOCAPROIC ACID; HEMOSTATIC AGENT; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ARTICLE; BRAIN HEMORRHAGE; CLINICAL PRACTICE; CLINICAL STUDY; CLINICAL TRIAL; DATA ANALYSIS; DATA COLLECTION METHOD; DRUG EFFECT; DRUG EFFICACY; HUMAN; MEDICAL RESEARCH; MEDLINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

EID: 33845940569     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000251797.86897.a3     Document Type: Article

References (1)

1. Diringer MN, Selchen D, Davis S, Mayer SA, Brun NC, Broderick J, Skolnick BE, Steiner T; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Safety profile of recombinant factor VIIa in patients with intracerebral hemorrhage. Stroke. 2006;37:623. Abstract.